Tissue Plasminogen Activator for Acute Ischemic Stroke
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
New England Journal of Medicine · 1995 · 11,769 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Group, T. N. I. of N. D. and S. rt-P. S. S. (1995). Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 333(24), 1581–1588. https://doi.org/10.1056/nejm199512143332401
In text: (Group, 1995)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Thrombolytic therapy for acute ischemic stroke has been approached cautiously because there were high rates of intracerebral hemorrhage in early clinical trials. We performed a randomized, double-blind trial of intravenous recombinant tissue plasminogen activator (t-PA) for ischemic stroke after recent pilot studies suggested that t-PA was beneficial when treatment was begun within three hours of the onset of stroke.
Related papers
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.1993
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke2008
- Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.1997
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease2012
- Vascular Contributions to Cognitive Impairment and Dementia2011
Metadata from OpenAlex (CC0). Citations are generated from the published record.